Cargando…

Risk factors for otitis media with effusion in children with adenoid hypertrophy

The aim of this study was to determine the most important risk factors in the development of otitis media with effusion (OME) in children with adenoid hypertrophy. A total of 539 patients undergoing surgery for adenoid hypertrophy (AH Group) (n = 429) or adenoid hypertrophy and otitis media with eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Songu, Murat, Islek, Akif, Imre, Abdulkadir, Aslan, Hale, Aladag, Ibrahim, Pinar, Ercan, Oncel, Semih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore Srl 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256910/
https://www.ncbi.nlm.nih.gov/pubmed/32469007
http://dx.doi.org/10.14639/0392-100X-2456
_version_ 1783540015138078720
author Songu, Murat
Islek, Akif
Imre, Abdulkadir
Aslan, Hale
Aladag, Ibrahim
Pinar, Ercan
Oncel, Semih
author_facet Songu, Murat
Islek, Akif
Imre, Abdulkadir
Aslan, Hale
Aladag, Ibrahim
Pinar, Ercan
Oncel, Semih
author_sort Songu, Murat
collection PubMed
description The aim of this study was to determine the most important risk factors in the development of otitis media with effusion (OME) in children with adenoid hypertrophy. A total of 539 patients undergoing surgery for adenoid hypertrophy (AH Group) (n = 429) or adenoid hypertrophy and otitis media with effusion (AH + OME Group) (n = 110) between February 2012 and February 2018 constituted the study group. Data were obtained on neonatal history (breastfeeding, bottle feeding), past health and medical history (presence of atopy or allergic rhinitis, snoring at night, cough, tonsillitis in the past 12 months), environmental factors (presence of pets, attending to daycare centers, district of school), family history (passive smoking at home, number of siblings, family size, parental education), and family income. The groups did not differ from each other for age (p = 0.684) and gender (p = 0.728). Our data support the presence of atopy or allergic rhinitis (p < 0.001), frequent (> 5) tonsillitis (p < 0.001), attending to daycare centers (p < 0.001), exposure to smoke (p < 0.001), having 3 or more siblings (p < 0.001), and 4 or more people in the household (p < 0.001) as the main risk factors for OME. Comprehensive knowledge of modifiable risk factors found in this study could help to minimise the complications of OME in children.
format Online
Article
Text
id pubmed-7256910
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Pacini Editore Srl
record_format MEDLINE/PubMed
spelling pubmed-72569102020-06-08 Risk factors for otitis media with effusion in children with adenoid hypertrophy Songu, Murat Islek, Akif Imre, Abdulkadir Aslan, Hale Aladag, Ibrahim Pinar, Ercan Oncel, Semih Acta Otorhinolaryngol Ital Osahs The aim of this study was to determine the most important risk factors in the development of otitis media with effusion (OME) in children with adenoid hypertrophy. A total of 539 patients undergoing surgery for adenoid hypertrophy (AH Group) (n = 429) or adenoid hypertrophy and otitis media with effusion (AH + OME Group) (n = 110) between February 2012 and February 2018 constituted the study group. Data were obtained on neonatal history (breastfeeding, bottle feeding), past health and medical history (presence of atopy or allergic rhinitis, snoring at night, cough, tonsillitis in the past 12 months), environmental factors (presence of pets, attending to daycare centers, district of school), family history (passive smoking at home, number of siblings, family size, parental education), and family income. The groups did not differ from each other for age (p = 0.684) and gender (p = 0.728). Our data support the presence of atopy or allergic rhinitis (p < 0.001), frequent (> 5) tonsillitis (p < 0.001), attending to daycare centers (p < 0.001), exposure to smoke (p < 0.001), having 3 or more siblings (p < 0.001), and 4 or more people in the household (p < 0.001) as the main risk factors for OME. Comprehensive knowledge of modifiable risk factors found in this study could help to minimise the complications of OME in children. Pacini Editore Srl 2020-04 /pmc/articles/PMC7256910/ /pubmed/32469007 http://dx.doi.org/10.14639/0392-100X-2456 Text en Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en This is an open access article distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-Non-Commercial-NoDerivatives 4.0 International) license. The article can be used by giving appropriate credit and mentioning the license, but only for non-commercial purposes and only in the original version. For further information: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
spellingShingle Osahs
Songu, Murat
Islek, Akif
Imre, Abdulkadir
Aslan, Hale
Aladag, Ibrahim
Pinar, Ercan
Oncel, Semih
Risk factors for otitis media with effusion in children with adenoid hypertrophy
title Risk factors for otitis media with effusion in children with adenoid hypertrophy
title_full Risk factors for otitis media with effusion in children with adenoid hypertrophy
title_fullStr Risk factors for otitis media with effusion in children with adenoid hypertrophy
title_full_unstemmed Risk factors for otitis media with effusion in children with adenoid hypertrophy
title_short Risk factors for otitis media with effusion in children with adenoid hypertrophy
title_sort risk factors for otitis media with effusion in children with adenoid hypertrophy
topic Osahs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256910/
https://www.ncbi.nlm.nih.gov/pubmed/32469007
http://dx.doi.org/10.14639/0392-100X-2456
work_keys_str_mv AT songumurat riskfactorsforotitismediawitheffusioninchildrenwithadenoidhypertrophy
AT islekakif riskfactorsforotitismediawitheffusioninchildrenwithadenoidhypertrophy
AT imreabdulkadir riskfactorsforotitismediawitheffusioninchildrenwithadenoidhypertrophy
AT aslanhale riskfactorsforotitismediawitheffusioninchildrenwithadenoidhypertrophy
AT aladagibrahim riskfactorsforotitismediawitheffusioninchildrenwithadenoidhypertrophy
AT pinarercan riskfactorsforotitismediawitheffusioninchildrenwithadenoidhypertrophy
AT oncelsemih riskfactorsforotitismediawitheffusioninchildrenwithadenoidhypertrophy